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Abstract 
 
Health state preference data are increasingly used to inform national health 
care resource allocation decisions. In such circumstances it is important to be 
confident that the data we provide to decision makers is fit for purpose. Whilst 
there are many unresolved issues in health state preference measurement, 
there are some areas of agreement on procedures that are inappropriate. The 
past ten years have seen the publication of a number of papers reporting 
substantive problems with the use of visual analogue scales to value health 
states. In this journal Torrance and colleagues reviewed this literature and 
concluded that Visual Analogue Scales have a limited but useful role in health 
state preference measurement. In this paper we critically review the 
arguments advanced by Torrance and colleagues and argue that it is 
increasingly clear that Visual Analogue Scales are not an appropriate method 
and that the time has come to accept that VAS should not be used for health 
state preference measurement. 
 Background 
The results of health state preference measurement play an increasingly 
central role in public health care resource allocation decision making 
processes. 1 2 3 4  In such circumstances it is important to have confidence 
that the data we provide to decision makers is fit for purpose. Health state 
preference data is produced through a process of addressing five specific 
questions: 
· How should we describe health? 
· How should we measure health? 
· How should we value health? 
· Whose values should we use?  
· How should values be aggregated? 
 
In establishing whether health state preference data are fit for purpose, one 
has to consider the way in which each of these questions has been answered 
in the process of its production.5  The current state of knowledge does not 
provide a consensus on the ‘correct’ answer to any of these questions. 
However, there is increasing agreement that certain answers are incorrect; for 
example it is no longer considered acceptable to use doctors’ values of 
patients’ health states to inform resource allocation decisions. 1 4 6 In this 
paper we argue that the state of knowledge regarding the Visual Analogue 
Scale data has reached the point that its use in health state preference 
measurement should now be viewed as an ‘incorrect’ answer to the question 
‘How should we value health?’. 
 
Visual Analogue Scales 
 
The visual analogue scale (VAS) was originally developed to allow the 
measurement of individual’s responses to physical stimuli, such as heat.7 VAS 
have been a mainstay of health state preference measurement for over 30 
years and is central to the development of health state preference weights for 
many of the most widely used health related quality of life measures; including 
the Quality of Well Being Index, the EQ-5D and the Health Utilities Indices.8 9 
10 11  
 
A VAS consists of a line on a page with clearly defined end points, and 
normally a clearly identified scale between the two end points. When VAS is 
used to obtain health state preference data, individuals are instructed to place 
the most preferred health state (e.g. full health) at one end of the line and the 
least preferred health state at the other end of the line. The health states for 
valuation are then located at points on the line that correspond to how much 
better and/or worse than the other health states they believe each one to be. 12  
 
The single greatest appeal of the VAS for health state valuation is its simplicity 
of use. In their review of the health state valuation literature, Brazier et al 
reported that completion rates for VAS based surveys were typically in excess 
of 90%.7 However, there is now a substantial body of research on the 
limitations of VAS as a means of health state preference measurement. This 
literature has been reviewed in detail elsewhere, and so we will only present 
the key problems here.7  
 
It is increasingly accepted that VAS health state preference data are 
subjected to a number of biases; notably context and spreading bias, and 
end-point aversion. 10 18   In addition, many researchers question whether 
there is a stable relationship between VAS health state valuation data and 
choice based valuation data such as Standard Gamble (SG) and Time Trade 
Off (TTO).13 14 The manner in which VAS has been used by Torrance and 
colleagues, and other researchers, assumes such a stable relationship exists.  
Some researchers go as far as arguing that VAS data do not capture 
preferences at all.15 16 17 Finally, some researchers question whether VAS is 
as simple for the respondent as is often assumed. 18  
 
In reviewing this literature, Torrance and colleagues argued that there was still 
a limited but important role for VAS in health state preference measurement. 
They stated that VAS “can, however, play a useful role if used with caution in 
conjunction with the SG or possibly the TTO.” (p333). They went on to identify 
the following roles for VAS: 18 
 
1. It can be used to familiarize the respondents with the health states and 
to obtain ordinal preferences; 
2. It can be used to obtain cardinal health state preferences for some 
health states that are not subsequently measured with SG or TTO.  
a. In such circumstances, a study specific power curve should be 
developed to adjust the VAS scores for those states not 
measured by the SG or the TTO. (p333) 
b. It is unclear whether it is better to debias the VAS scores prior 
to the estimation of the power curve or not. (p333). 
 
In this paper we critically review Torrance et al.’s recommendations for the 
use of VAS, and argue that the problems with VAS are so substantial, and its 
advantages so limited, that its use in health state preference measurement 
should be abandoned. 
 
Using VAS to obtain ordinal health state preferences. 
 
Ordinal health state preference data provides information on whether the 
respondent prefers Statse A to State B, or vice versa. They do not provide any 
information on the strength of the preference for State A versus B.  The 
definition of VAS provided by Torrance et al, makes it clear that with VAS 
data, the distance between States A and B, has some meaning; i.e. it is 
intended to provide cardinal preference data. Ordinal preference data can be 
obtained through simple ranking exercises; i.e. where the respondent is asked 
to place health states in order to represent whether State A is preferred to 
State B; but not how much better State A is preferred to State B. The United 
Kingdom EQ-5D, SF-6D and UK Health Utilities Index Mark 2 valuation 
studies have all successfully used such ranking exercises to obtain ordinal 
preference data to familiarise the respondents with the health states. 23 24 25 
These data have subsequently been used to estimate health state valuation 
models. 19 20 Whilst VAS data undoubtedly provide ordinal health state 
preferences, it is not obvious that VAS offers anything that is not provided by 
the ranking exercise. If the respondent is instructed that the distance between 
the states on the VAS should represent their strength of preference between 
health states,21 22 it seems likely that the respondent burden will be 
significantly increased using VAS as a prop, compared to the simple ranking 
exercises used elsewhere. 
 
Using VAS to obtain cardinal health state preferences for states 
that are not subsequently valued using SG or TTO 
 
The use of VAS to obtain cardinal health state preferences directly is 
generally deemed necessary when the number of health states to be valued is 
too large to allow the use of the SG or TTO technique.22 The point at which 
the SG or the TTO cease to be feasible has not been established. The UK 
HUI2 valuation obtained 8 SG valuations from each respondent; the SF-6D 
study obtained 6 SG valuations from each respondent and UK EQ-5D study 
obtained 13 TTO valuations from each respondent.23 24 25 
 
Whilst Torrance et al suggest that the maximum number of states to be valued 
simultaneously on a single VAS is in the region of 6;18 many studies have 
valued considerably more. 26 27 28 29  
 
The Canadian HUI2 valuation study required over 20 separate health state 
valuations from each respondent.28 This was necessary because the study 
was designed to estimate individual multi-attribute utility functions (MAUF) for 
each respondent, in addition to a population MAUF. In studies designed to 
estimate population utility functions, factorial survey designs, such as that 
utilised in the HUI3 and UK EQ-5D study, allow the number of health states 
valued by each respondent to be reduced by increasing the number of 
respondents.26 24 Therefore, with the exception of research to construct 
individual MAUFs, respondent burden does not create a case for the use of 
VAS in health state preference measurement.  
 Against this background, we recognise that many researchers may find the 
perceived convenience of the VAS compared to SG and TTO a sufficient 
justification. To quote Torrance et al  “VASs are attractive because they are 
simple, quick to administer and lend themselves to self completion.” (p333). 18 
In the next section, we consider the evidence base for Torrance et al.’s 
recommendation when VAS is being used to collect cardinal health state 
preference data. 
 
Estimating a study specific power function 
 
Torrance and colleagues recommend the estimation of a study-specific power 
function, and not the use of power functions estimated on other datasets. 1 
They note that whilst it had “originally been hoped that a single consistent 
power function would be found between VAS scores and SG scores in all 
studies…it was not to be.” (p332)  
 
They argue for a power curve on two grounds; first they note that both the 
(adjusted) VAS and SG scales anchor at dead=0.0 and healthy=1.0. Thus any 
systematic relationship between VAS and SG would have to pass through 0 
and 1. The power function is a simple function that meets these requirements.  
Secondly, they argue that the power curve has been consistently required in 
applied research even when the data have been adjusted for end-aversion 
bias or context bias.26 27  
 
With regard to the first point, there are a number of other functional forms that 
can be constrained to pass through the points 0 and 1; including the quadratic 
and cubic functions.29 30 31 With regard to the second point, there is now some 
empirical evidence suggesting that linear, quadratic and cubic functions (all 
passing through the points 0 and 1) can provide a better fit than the power 
function for VAS-SG data, both in individual and person-mean data. 31 29  
 
                                            
1 Unfortunately this is quite frequently what is done in practice.1 
Considering that the power function has not been found to be robust across 
datasets; it seems reasonable to consider whether the power function is 
robust between health states within a single dataset. This is a central 
assumption of the use of VAS-SG mapping functions and yet to our 
knowledge this issue has not been explored in the literature.  
 
In other places it has been argued that the power function is appropriate on a 
theoretical basis; i.e. it reflects a constant relative risk attitude. This argument 
defines VAS data as values; i.e, preferences under conditions of certainty and 
SG data as utilities; where utilities represent preferences under conditions of 
uncertainty.30    
 
Bleichrodt and Johannesson tested the proposal that VAS elicited points on a 
measurable value function and whether VAS and SG values were linked by a 
constant relative risk attitude.32 Their analyses rejected both hypotheses. 
Schwartz subsequently found that Bleichrodt and Johannesson’s data were 
consistent with the VAS eliciting values on a measurable value function, once 
the VAS data had been adjusted to take account of context bias using the 
Range-Frequency (RF) model.33 However, Schwartz did not test whether the 
power function fitted the adjusted data.34 Robinson et al, in a separate 
dataset, also found that VAS data that had been adjusted using the Range-
Frequency model were consistent with VAS eliciting points on a measurable 
value function. 35  When they attempted to map the revised data on to SG 
utilities for the same states, they found that the power curve was a poor 
specification for the relationship. 
 
It is worth noting, in passing, that when the RF model is applied to VAS data 
where the highest ranked state is given a value of 1, the adjusted value for 
this state will also be 1, irrespective of the value given to the parameter w.2  
The effect of this is to produce data that are no longer on the 0-1 scale 
required for estimating utility weights in the QALY model and which cannot be 
                                            
2 w is the parameter determining the relative weight given to the range and frequency effects 
in the range frequency model. It ranges between 0 and 1. 
translated on to this scale using a linear transformation because the true 
adjusted value of the upper anchor of the scale is unknown.   
 
The solution to this problem is to apply a linear transformation to the VAS data 
prior to the application of the RF model; an obvious candidate transformation 
being to map the VAS data on to a 0-100 scale.  The RF model can then be 
applied to the transformed data. A second linear transformation can then be 
applied to express the adjusted (unbiased values) on the desired 0-1 scale.  
 
If VAS data are not adjusted for RF bias, then any power function estimated 
on the unadjusted data will also be biased, because the effect of the RF bias 
is not constant across the range. To date, none of the published health state 
valuation models that have utilised the power curve transformation, have 
applied the RF model adjustment to the VAS data prior to model estimation. 
Therefore, it is reasonable to assume that these models have been estimated 
on biased data, and will in turn produce biased estimates. 
 
Torrance and colleagues identify end-point bias as an additional consideration 
when using VAS to measure health state preferences.18 It is unclear what, if 
any interaction there might be between RF and end-point bias, or whether a 
simple adjustment for end-point bias followed by the application of the Range 
Frequency model would adequately remove the bias from the data.   
 
The use of VAS to obtain cardinal health state preference data commits the 
researcher to undertaking a number of adjustments to the data: the RF model, 
end-point bias adjustment, and mapping to utilities; prior to estimating a  
health state utility model.  Simplicity in VAS data collection, we would argue, is 
outweighed by complexity and uncertainty in its utilisation. 
 
Summary 
 
Considering the experience of three substantial health state valuation studies 
in the UK,23 24 25 we doubt whether VAS offers anything to the elicitation of 
ordinal health state preferences, over and above simple ranking exercises. 
The same studies indicate that the number of health states that can be 
successfully valued using choice based methods, such as the SG or TTO, is 
such that respondent burden is unlikely to create a real need to use VAS to 
measure health state preferences. Further, in circumstances where the 
number of states to be valued is large, we would argue that individual 
respondent burden can be managed through the application of factorial 
survey designs, without sacrificing the use of choice based valuation methods, 
as long as the objective is to estimate population rather than individual 
valuation functions. Finally, the evidence is increasingly strong that VAS data 
are subject to bias, and the methods for adjusting for this bias have not been 
resolved, and even when concerns over bias have been set aside, we would 
argue that we do not know the functional form of the relationship between 
these ‘Values’ and the preferences that we are actually trying to measure. All 
we can say with confidence is that the power function is a poor model. 
 
For these reasons, we would argue that it is time to acknowledge that VAS do 
not have a useful role in health state preference measurement. 
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